Genomic Biomarker Market, Global Outlook and Forecast 2022-2028

March 2022 | 104 pages | ID: GDC8623BA791EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Genomic Biomarker in Global, including the following market information:

Global Genomic Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Genomic Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Protein Marker Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Genomic Biomarker include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genomic Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genomic Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Genomic Biomarker Market Segment Percentages, by Type, 2021 (%)

• Protein Marker
• Nucleic Acid Marker
• Other

Global Genomic Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Genomic Biomarker Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic and research laboratories

Global Genomic Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Genomic Biomarker Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Genomic Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Genomic Biomarker revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bio-Rad
• Beckman Coulter
• Myriad Genetics
• Thermo Fisher Scientific
• Roche
• QIAGEN
• Epigenomics
• Almac
• Pfizer
• Human Longevity
• ValiRx
• Personalis
• Eagle Genomics
• Empire Genomics
• Agilent
• Illumina

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genomic Biomarker Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genomic Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENOMIC BIOMARKER OVERALL MARKET SIZE

2.1 Global Genomic Biomarker Market Size: 2021 VS 2028
2.2 Global Genomic Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genomic Biomarker Players in Global Market
3.2 Top Global Genomic Biomarker Companies Ranked by Revenue
3.3 Global Genomic Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Genomic Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genomic Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomic Biomarker Players in Global Market
  3.6.1 List of Global Tier 1 Genomic Biomarker Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genomic Biomarker Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Genomic Biomarker Market Size Markets, 2021 & 2028
  4.1.2 Protein Marker
  4.1.3 Nucleic Acid Marker
  4.1.4 Other
4.2 By Type - Global Genomic Biomarker Revenue & Forecasts
  4.2.1 By Type - Global Genomic Biomarker Revenue, 2017-2022
  4.2.2 By Type - Global Genomic Biomarker Revenue, 2023-2028
  4.2.3 By Type - Global Genomic Biomarker Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genomic Biomarker Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic and research laboratories
5.2 By Application - Global Genomic Biomarker Revenue & Forecasts
  5.2.1 By Application - Global Genomic Biomarker Revenue, 2017-2022
  5.2.2 By Application - Global Genomic Biomarker Revenue, 2023-2028
  5.2.3 By Application - Global Genomic Biomarker Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Genomic Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Genomic Biomarker Revenue & Forecasts
  6.2.1 By Region - Global Genomic Biomarker Revenue, 2017-2022
  6.2.2 By Region - Global Genomic Biomarker Revenue, 2023-2028
  6.2.3 By Region - Global Genomic Biomarker Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Genomic Biomarker Revenue, 2017-2028
  6.3.2 US Genomic Biomarker Market Size, 2017-2028
  6.3.3 Canada Genomic Biomarker Market Size, 2017-2028
  6.3.4 Mexico Genomic Biomarker Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Genomic Biomarker Revenue, 2017-2028
  6.4.2 Germany Genomic Biomarker Market Size, 2017-2028
  6.4.3 France Genomic Biomarker Market Size, 2017-2028
  6.4.4 U.K. Genomic Biomarker Market Size, 2017-2028
  6.4.5 Italy Genomic Biomarker Market Size, 2017-2028
  6.4.6 Russia Genomic Biomarker Market Size, 2017-2028
  6.4.7 Nordic Countries Genomic Biomarker Market Size, 2017-2028
  6.4.8 Benelux Genomic Biomarker Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Genomic Biomarker Revenue, 2017-2028
  6.5.2 China Genomic Biomarker Market Size, 2017-2028
  6.5.3 Japan Genomic Biomarker Market Size, 2017-2028
  6.5.4 South Korea Genomic Biomarker Market Size, 2017-2028
  6.5.5 Southeast Asia Genomic Biomarker Market Size, 2017-2028
  6.5.6 India Genomic Biomarker Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Genomic Biomarker Revenue, 2017-2028
  6.6.2 Brazil Genomic Biomarker Market Size, 2017-2028
  6.6.3 Argentina Genomic Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genomic Biomarker Revenue, 2017-2028
  6.7.2 Turkey Genomic Biomarker Market Size, 2017-2028
  6.7.3 Israel Genomic Biomarker Market Size, 2017-2028
  6.7.4 Saudi Arabia Genomic Biomarker Market Size, 2017-2028
  6.7.5 UAE Genomic Biomarker Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bio-Rad
  7.1.1 Bio-Rad Corporate Summary
  7.1.2 Bio-Rad Business Overview
  7.1.3 Bio-Rad Genomic Biomarker Major Product Offerings
  7.1.4 Bio-Rad Genomic Biomarker Revenue in Global Market (2017-2022)
  7.1.5 Bio-Rad Key News
7.2 Beckman Coulter
  7.2.1 Beckman Coulter Corporate Summary
  7.2.2 Beckman Coulter Business Overview
  7.2.3 Beckman Coulter Genomic Biomarker Major Product Offerings
  7.2.4 Beckman Coulter Genomic Biomarker Revenue in Global Market (2017-2022)
  7.2.5 Beckman Coulter Key News
7.3 Myriad Genetics
  7.3.1 Myriad Genetics Corporate Summary
  7.3.2 Myriad Genetics Business Overview
  7.3.3 Myriad Genetics Genomic Biomarker Major Product Offerings
  7.3.4 Myriad Genetics Genomic Biomarker Revenue in Global Market (2017-2022)
  7.3.5 Myriad Genetics Key News
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Corporate Summary
  7.4.2 Thermo Fisher Scientific Business Overview
  7.4.3 Thermo Fisher Scientific Genomic Biomarker Major Product Offerings
  7.4.4 Thermo Fisher Scientific Genomic Biomarker Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Genomic Biomarker Major Product Offerings
  7.5.4 Roche Genomic Biomarker Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 QIAGEN
  7.6.1 QIAGEN Corporate Summary
  7.6.2 QIAGEN Business Overview
  7.6.3 QIAGEN Genomic Biomarker Major Product Offerings
  7.6.4 QIAGEN Genomic Biomarker Revenue in Global Market (2017-2022)
  7.6.5 QIAGEN Key News
7.7 Epigenomics
  7.7.1 Epigenomics Corporate Summary
  7.7.2 Epigenomics Business Overview
  7.7.3 Epigenomics Genomic Biomarker Major Product Offerings
  7.7.4 Epigenomics Genomic Biomarker Revenue in Global Market (2017-2022)
  7.7.5 Epigenomics Key News
7.8 Almac
  7.8.1 Almac Corporate Summary
  7.8.2 Almac Business Overview
  7.8.3 Almac Genomic Biomarker Major Product Offerings
  7.8.4 Almac Genomic Biomarker Revenue in Global Market (2017-2022)
  7.8.5 Almac Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Genomic Biomarker Major Product Offerings
  7.9.4 Pfizer Genomic Biomarker Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Human Longevity
  7.10.1 Human Longevity Corporate Summary
  7.10.2 Human Longevity Business Overview
  7.10.3 Human Longevity Genomic Biomarker Major Product Offerings
  7.10.4 Human Longevity Genomic Biomarker Revenue in Global Market (2017-2022)
  7.10.5 Human Longevity Key News
7.11 ValiRx
  7.11.1 ValiRx Corporate Summary
  7.11.2 ValiRx Business Overview
  7.11.3 ValiRx Genomic Biomarker Major Product Offerings
  7.11.4 ValiRx Genomic Biomarker Revenue in Global Market (2017-2022)
  7.11.5 ValiRx Key News
7.12 Personalis
  7.12.1 Personalis Corporate Summary
  7.12.2 Personalis Business Overview
  7.12.3 Personalis Genomic Biomarker Major Product Offerings
  7.12.4 Personalis Genomic Biomarker Revenue in Global Market (2017-2022)
  7.12.5 Personalis Key News
7.13 Eagle Genomics
  7.13.1 Eagle Genomics Corporate Summary
  7.13.2 Eagle Genomics Business Overview
  7.13.3 Eagle Genomics Genomic Biomarker Major Product Offerings
  7.13.4 Eagle Genomics Genomic Biomarker Revenue in Global Market (2017-2022)
  7.13.5 Eagle Genomics Key News
7.14 Empire Genomics
  7.14.1 Empire Genomics Corporate Summary
  7.14.2 Empire Genomics Business Overview
  7.14.3 Empire Genomics Genomic Biomarker Major Product Offerings
  7.14.4 Empire Genomics Genomic Biomarker Revenue in Global Market (2017-2022)
  7.14.5 Empire Genomics Key News
7.15 Agilent
  7.15.1 Agilent Corporate Summary
  7.15.2 Agilent Business Overview
  7.15.3 Agilent Genomic Biomarker Major Product Offerings
  7.15.4 Agilent Genomic Biomarker Revenue in Global Market (2017-2022)
  7.15.5 Agilent Key News
7.16 Illumina
  7.16.1 Illumina Corporate Summary
  7.16.2 Illumina Business Overview
  7.16.3 Illumina Genomic Biomarker Major Product Offerings
  7.16.4 Illumina Genomic Biomarker Revenue in Global Market (2017-2022)
  7.16.5 Illumina Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genomic Biomarker Market Opportunities & Trends in Global Market
Table 2. Genomic Biomarker Market Drivers in Global Market
Table 3. Genomic Biomarker Market Restraints in Global Market
Table 4. Key Players of Genomic Biomarker in Global Market
Table 5. Top Genomic Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genomic Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genomic Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genomic Biomarker Product Type
Table 9. List of Global Tier 1 Genomic Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomic Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genomic Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genomic Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genomic Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genomic Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genomic Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genomic Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genomic Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genomic Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genomic Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genomic Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genomic Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genomic Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genomic Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genomic Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genomic Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genomic Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genomic Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genomic Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genomic Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Bio-Rad Corporate Summary
Table 31. Bio-Rad Genomic Biomarker Product Offerings
Table 32. Bio-Rad Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Beckman Coulter Corporate Summary
Table 34. Beckman Coulter Genomic Biomarker Product Offerings
Table 35. Beckman Coulter Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Myriad Genetics Corporate Summary
Table 37. Myriad Genetics Genomic Biomarker Product Offerings
Table 38. Myriad Genetics Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Genomic Biomarker Product Offerings
Table 41. Thermo Fisher Scientific Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Genomic Biomarker Product Offerings
Table 44. Roche Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. QIAGEN Corporate Summary
Table 46. QIAGEN Genomic Biomarker Product Offerings
Table 47. QIAGEN Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Epigenomics Corporate Summary
Table 49. Epigenomics Genomic Biomarker Product Offerings
Table 50. Epigenomics Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. Almac Corporate Summary
Table 52. Almac Genomic Biomarker Product Offerings
Table 53. Almac Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Genomic Biomarker Product Offerings
Table 56. Pfizer Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. Human Longevity Corporate Summary
Table 58. Human Longevity Genomic Biomarker Product Offerings
Table 59. Human Longevity Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 60. ValiRx Corporate Summary
Table 61. ValiRx Genomic Biomarker Product Offerings
Table 62. ValiRx Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 63. Personalis Corporate Summary
Table 64. Personalis Genomic Biomarker Product Offerings
Table 65. Personalis Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 66. Eagle Genomics Corporate Summary
Table 67. Eagle Genomics Genomic Biomarker Product Offerings
Table 68. Eagle Genomics Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 69. Empire Genomics Corporate Summary
Table 70. Empire Genomics Genomic Biomarker Product Offerings
Table 71. Empire Genomics Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 72. Agilent Corporate Summary
Table 73. Agilent Genomic Biomarker Product Offerings
Table 74. Agilent Genomic Biomarker Revenue (US$, Mn), (2017-2022)
Table 75. Illumina Corporate Summary
Table 76. Illumina Genomic Biomarker Product Offerings
Table 77. Illumina Genomic Biomarker Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Genomic Biomarker Segment by Type in 2021
Figure 2. Genomic Biomarker Segment by Application in 2021
Figure 3. Global Genomic Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genomic Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genomic Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomic Biomarker Revenue in 2021
Figure 8. By Type - Global Genomic Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genomic Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genomic Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genomic Biomarker Revenue Market Share, 2017-2028
Figure 12. US Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genomic Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genomic Biomarker Revenue Market Share, 2017-2028
Figure 24. China Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genomic Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genomic Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genomic Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Bio-Rad Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Beckman Coulter Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Myriad Genetics Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. QIAGEN Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Epigenomics Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Almac Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Human Longevity Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ValiRx Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Personalis Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eagle Genomics Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Empire Genomics Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Agilent Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Illumina Genomic Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)